New York bills · 2025 Regular Session
New York A 9010
Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Linda Rosenthal (Democratic)
Cosponsors (6)
- Emily Gallagher (Democratic)
- Phil Steck (Democratic)
- MaryJane Shimsky (Democratic/Working Families)
- Jo Anne Simon (Democratic)
- Judy Griffin (Democratic)
- Steve Stern (Democratic)
Summary
Official abstract published by the New York legislature
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- May 4, 2026 · House
PRINT NUMBER 9010B - May 4, 2026 · House
AMEND AND RECOMMIT TO HEALTH - Jan 22, 2026 · House
PRINT NUMBER 9010A - Jan 22, 2026 · House
AMEND AND RECOMMIT TO HEALTH - Jan 7, 2026 · House
REFERRED TO HEALTH - Aug 13, 2025 · House
REFERRED TO HEALTH